“In 2015 we engaged with Brian Trust Bio on a comprehensive target discovery and small molecule scoring project which exhausted our pipeline at the time. Their team scouted for the most advanced technologies in the world and we were a natural fit in the artificial intelligence space. They have a very professional approach and we got to work with high-quality anonymized data sets that were compatible with our internal systems and data. ALS is one of the most interesting diseases for AI and this collaboration motivated us to start a therapeutic program and develop the ALS.AI platform. The Brian Trust Bio team is a pleasure to work with.”
